Bailard’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-3,900
| Closed | -$374K | – | 723 |
|
|
2020
Q4 | $374K | Hold |
3,900
| – | – | 0.02% | 391 |
|
|
2020
Q3 | $375K | Hold |
3,900
| – | – | 0.02% | 343 |
|
|
2020
Q2 | $476K | Hold |
3,900
| – | – | 0.03% | 276 |
|
|
2020
Q1 | $338K | Hold |
3,900
| – | – | 0.02% | 288 |
|
|
2019
Q4 | $419K | Sell |
3,900
-1,000
| -20% | -$107K | 0.02% | 337 |
|
|
2019
Q3 | $442K | Hold |
4,900
| – | – | 0.03% | 292 |
|
|
2019
Q2 | $414K | Hold |
4,900
| – | – | 0.03% | 331 |
|
|
2019
Q1 | $432K | Hold |
4,900
| – | – | 0.03% | 334 |
|
|
2018
Q4 | $350K | Hold |
4,900
| – | – | 0.02% | 388 |
|
|
2018
Q3 | $602K | Hold |
4,900
| – | – | 0.04% | 324 |
|
|
2018
Q2 | $481K | Hold |
4,900
| – | – | 0.03% | 375 |
|
|
2018
Q1 | $406K | Sell |
4,900
-2,000
| -29% | -$166K | 0.03% | 371 |
|
|
2017
Q4 | $535K | Buy |
+6,900
| New | +$535K | 0.03% | 305 |
|